Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responses
Preprint
Abstract
SUMMARY: Atomic layer deposition (ALD), a new vaccine technology, permits multiple dosing with a single administration by pulsatile release of one or more immunogens. We evaluated ALD delivery of mosaic-8b [60-mer nanoparticles presenting 8 different SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs)] that elicits broadly cross-reactive antibodies and protects against mismatched sarbecoviruses not represented by RBDs on mosaic-8b. Compared with conventional prime-boost immunizations, ALD-delivered mosaic-8b RBD-nanoparticles elicited antibodies in both naïve and pre-vaccinated mice with improved mismatched binding and neutralization. Results of RBD epitope mapping of serum antibodies from ALD-delivered mosaic-8b were consistent with broader coverage of RBD epitopes compared to conventional immunizations, and systems serology revealed distinct IgG subclass and FcγR-binding IgG distributions. These results suggest that ALD is a promising technology for use with mosaic-8b RBD-nanoparticle vaccines to protect against future sarbecovirus spillovers and support applications for ALD vaccine delivery to elicit cross-reactive antibodies against rapidly mutating or diverse pathogens.Keywords
All Related Versions
- Published version: iScience, 28 (11), 113649.
Funding Information
- Welcome Leap (N/A)
- Bill and Melinda Gates Foundation (INV-034638)
- Bill and Melinda Gates Foundation (INV-002149/INV-042180)
This publication has 62 references indexed in Scilit:
- Designed mosaic nanoparticles enhance cross-reactive immune responses in miceCell, 2025
- A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceCell Host & Microbe, 2024
- Transforming vaccinologyCell, 2024
- Lipid nanoparticle‐mediated RNA delivery for immune cell modulationEuropean Journal of Immunology, 2024
- Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsCell, 2024
- Broad receptor tropism and immunogenicity of a clade 3 sarbecovirusCell Host & Microbe, 2023
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesCell Reports, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesCell, 2020
- Particle atomic layer depositionJournal of Nanoparticle Research, 2019